Vertically integrated cannabis company Sunniva (CSE: SNN) (OTCQX: SNNVF) this morning announced that its wholly owned subsidiary, Sunniva Medical Inc. (“SMI”), has received the Confirmation of Readiness from Health Canada for a license under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). Now that the application has been accepted, the next step will be an inspection upon site readiness to begin cultivation. SMI will be required to provide information including documentation, photos, and videos of the Sunniva Canada Campus to present evidence of all physical security measures in order to confirm readiness and receive a cultivation license from Health Canada. Additionally, SMI has received development approval from the Regional District of Okanagan-Similkameen for construction of the Sunniva Canada Campus on its recently-purchased 126-acre site in Okanagan Falls, British Columbia. “We are pleased to deliver on another key corporate milestone for the company as we have made an excellent start to 2018 with significant progress on multiple fronts, executing on our strategy, and working toward our goal of creating one of the most efficient, low-cost growing operations to serve the Canadian and California cannabis market,” Sunniva CEO Dr. Anthony Holler stated in the news release. “It is our intention to forward sell an additional 30% of our production capacity in Canada”.
To view the full press release, visit http://ibn.fm/x5VlY
About Sunniva Inc.
Sunniva, through its subsidiaries, is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – where it is committed to delivering safe, high-quality products and services at scale. The company’s vision is to become the lowest cost, highest quality cannabis producer in the markets it serves by building large scale purpose-built current good manufacturing practices greenhouses, offering better quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education and sourcing better therapeutic delivery devices. Sunniva’s management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries. For more information, visit the company’s website at www.Sunniva.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
